Because α-FP, α-FP-L3, GP73, and OPN are insufficient as standalone biomarkers for early detection of HCC and DCP, DKK1, and MDK seem promising among α-FP non-secretors, they may be helpful in a biomarker panel-based screening strategy. This evidence concerns the gene ACE and hepatocellular carcinoma.